Free tool
FAERS Monitor: Tiazac
Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020401 or its brand name (Tiazac, Diltiazem Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
14,189
Serious
11,748
83% of reports
Hospitalization
6,405
Death reported
3,065
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea1,651
- pain1,374
- fatigue1,369
- fall1,194
- diarrhoea1,094
- headache1,073
- nausea1,070
- arthralgia1,033
- dizziness1,031
- drug ineffective999
- hypotension944
- pruritus934
- pyrexia911
- off label use885
- condition aggravated875
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 569 |
| 2005 | 571 |
| 2006 | 378 |
| 2007 | 264 |
| 2008 | 247 |
| 2009 | 270 |
| 2010 | 332 |
| 2011 | 327 |
| 2012 | 428 |
| 2013 | 366 |
| 2014 | 445 |
| 2015 | 540 |
| 2016 | 473 |
| 2017 | 365 |
| 2018 | 412 |
| 2019 | 452 |
| 2020 | 644 |
| 2021 | 953 |
| 2022 | 1,478 |
| 2023 | 1,146 |
| 2024 | 1,383 |
| 2025 | 1,345 |
| 2026 | 801 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,970 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hypotensionSignal | 944 | 7.0 | 6.6 | 4,876 |
| fallSignal | 1,194 | 5.3 | 5.1 | 4,252 |
| dyspnoeaSignal | 1,651 | 4.3 | 4.1 | 4,334 |
| condition aggravatedSignal | 875 | 4.3 | 4.0 | 2,218 |
| pyrexiaSignal | 911 | 3.9 | 3.7 | 1,998 |
| arthralgiaSignal | 1,033 | 3.7 | 3.5 | 2,058 |
| pruritusSignal | 934 | 3.6 | 3.4 | 1,787 |
| painSignal | 1,374 | 3.3 | 3.2 | 2,288 |
| dizzinessSignal | 1,031 | 3.1 | 2.9 | 1,467 |
| fatigueSignal | 1,369 | 2.6 | 2.5 | 1,407 |
| headacheSignal | 1,073 | 2.5 | 2.4 | 1,029 |
| diarrhoeaSignal | 1,094 | 2.5 | 2.4 | 1,027 |
| nauseaSignal | 1,070 | 2.0 | 1.9 | 559 |
| off label use | 885 | 1.5 | 1.4 | 153 |
| drug ineffective | 999 | 1.1 | 1.1 | 14 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.